TuHURA Biosciences (HURA) Research & Development (2012 - 2026)
TuHURA Biosciences' Research & Development came in at $6.62 million for Q2 2026, up 34.4% from $4.93 million a year earlier and up 26.5% from the prior quarter.
Powered by 
Analysis
TuHURA Biosciences (HURA) Research & Development (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, TuHURA Biosciences reported Research & Development of $22.88 million, up 5.5% year-over-year; for FY2025, it was $20.53 million, up 54.0% from FY2024.
- Research & Development carries a five-year compound annual growth rate of 41.4% (FY2020 to FY2025).
- Going back by year, Research & Development was $13.34 million in FY2024 (+41.8%), $9.4 million in FY2023, $15.17 million in FY2022 (+28.4%) and $11.82 million in FY2021 (+225.5%).
- The Q2 2026 figure represents the highest quarterly Research & Development in data going back to Q1 2012.
- Business Quant data shows HURA's Research & Development at $5.23 million (Q1 2026), $6.06 million (Q4 2025) and $4.97 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | TuHURA Biosciences | 96.16 Mn | 82.54 Mn | - | 6.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.62 Mn |
| Mar 31, 2026 | 5.23 Mn |
| Dec 31, 2025 | 6.06 Mn |
| Sep 30, 2025 | 4.97 Mn |
| Jun 30, 2025 | 4.93 Mn |
| Mar 31, 2025 | 4.58 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 111,000.00 |
| Sep 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 2.06 Mn |
| Sep 30, 2022 | 3.17 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 3.47 Mn |
| Dec 31, 2021 | 3.90 Mn |
| Sep 30, 2021 | 3.79 Mn |
| Jun 30, 2021 | 4.03 Mn |
| Mar 31, 2021 | 3.84 Mn |
API Access
TuHURA Biosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=HURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "HURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=HURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();